Polysaccharides from Paecilomyces hepiali Prevent Acute Colitis in Association with Modulating Gut Microbiota and Treg/Th17 Immune Balance in Mice
Molecules · 2023
DOI: 10.3390/molecules28134984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Luwen Cui und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Qingdao University, Qingdao 266071, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Colitis, Ulcerative. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qingdao National Laboratory for Marine Science and technology Shandong special fund, Shandong Provincial Youth Entrepreneurship Program for Colleges and Universities, Shandong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Cordyceps exopolysaccharide (CEP) has shown emerging potential in adjustment of gut microbiota and immune cell function. In this study, a water-soluble CEP with a molecular weight of 58.14 kDa was extracted from the fermentation broth of Paecilomyces hepiali, an endophytic fungus of Cordyceps sinensis. Our results indicated that Paecilomyces hepiali polysaccharide (PHP) showed significantly preventive potential on dextran sulfate sodium (DSS)-induced colitis in mice, which can prevent colon shortening, reduce intestinal epithelial cell (IEC) destruction, suppress inflammatory cell infiltration, and regulate the balance between regulatory T (Treg) cells and T helper type 17 (Th17) cells. Meanwhile, the disturbed gut microbiota was partially restored after PHP treatment. Further Pearson correlation coefficient analyses exhibited that the alteration of the gut microbiota was significantly related to adjustment of the IEC barrier and Treg/Th17 balance. In conclusion, all findings proposed that purified PHP has the potential to develop into a promising agent for colitis prevention and adjuvant therapy via maintaining intestinal homeostasis of gut microbiota and immune system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Qingdao University, Qingdao 266071, China.
- Key Laboratory of Sustainable Development of Polar Fishery, Ministry of Agriculture and Rural Affairs, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao 266071, China.
- Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao 266000, China.
ORCID-Profile: Shengnan Yu, Jianhua Hao
Förderung
- Qingdao National Laboratory for Marine Science and technology Shandong special fund
- Shandong Provincial Youth Entrepreneurship Program for Colleges and Universities
- Shandong Provincial Natural Science Foundation
- Shandong Medical and Health Science and Technology Development Plan
Zitieren
APA
Cui, L., He, N., Yu, S., Pang, H., Zhang, Z., Wang, J., Hao, J., & Li, S. (2023). Polysaccharides from Paecilomyces hepiali Prevent Acute Colitis in Association with Modulating Gut Microbiota and Treg/Th17 Immune Balance in Mice. Molecules. https://doi.org/10.3390/molecules28134984
Vancouver
Cui L, He N, Yu S, Pang H, Zhang Z, Wang J, et al. Polysaccharides from Paecilomyces hepiali Prevent Acute Colitis in Association with Modulating Gut Microbiota and Treg/Th17 Immune Balance in Mice. Molecules. 2023. doi:10.3390/molecules28134984
BibTeX
@article{Cui2023,
author = {Cui, Luwen and He, Ningning and Yu, Shengnan and Pang, Hao and Zhang, Zixuan and Wang, Jingyi and Hao, Jianhua and Li, Shangyong},
title = {Polysaccharides from Paecilomyces hepiali Prevent Acute Colitis in Association with Modulating Gut Microbiota and Treg/Th17 Immune Balance in Mice},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28134984}
}
EUVIMED